Cardiff Oncology, Inc.
- CRDF
- NASDAQ
- Biotechnology
- Oncology (PLK1 Inhibitor)
- Targeted Cancer Therapies
$0.90
Today −7.20%Quote Oct 16, 2026, 08:00 PM UTC
−30.68%over the last month
Max drawdown −34.2%From 1-month high −34.2%3 months +7.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$70.1M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$2.00
+122.0% from here
Floor
$0.87
3.8% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CRDFPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
31
Founded
1999